2. Clinical and Medical Evaluation Process:STATISTICAL ISSUES IN THE DRUG EVALUATION PROSESS : SOME ISSUES IN APPLYING THE ICH GUIDELINES

スポンサーリンク

概要

• 論文の詳細を見る

• The International Conference on Harmonization (ICH) has recently developed the ICH guidelines, which are the common guidelines for regulatory requirements in the ICH regions, i.e. Japan, and the United States (US) and Europe. The guidelines have been implemented in the three regions, and the people involved in drug evaluation in the pharmaceutical industry, such as statisticians and pharmaceutical scientists, have referred the guidelines to their daily work when they perform the drug evaluation process. This paper aims to discuss some statistical issues in the drug evaluation process that are commonly encountered when applying the ICH guidelines. It also provides a few practical ideas for the future drug evaluation process. In this paper the emphasis is placed on the following ICH guidelines: "Dose-Response Information to Support Drug Registration" (ICH-E4), "Ethnic Factors in the Acceptability of Foreign Clinical Data" (ICH-E5) and "Choice of Control Group in Clinical Trials" (ICH-E10).

• 日本計算機統計学会の論文

日本計算機統計学会 | 論文

• MCMC法に基づく多変量階層線形データの分析(セッション5A(学生研究発表賞セッションII))
• コンテンツ・アプリケーション連動型複合統計教材開発と授業への展開(セッション4A)
• 初等中等教育を支援するコンテンツ・アプリケーション連動型複合統計教材の開発(セッション6A)
• 非対称可変分類法のシミュレーションによる評価
• 級内相関係数に関するパーミュテーションテストについて

もっと見る

スポンサーリンク